|
Market Closed -
Nasdaq
23:00:00 18/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.2066 USD | +0.78% |
|
-7.56% | -58.51% |
| Market Cap | 11.68M 10.09M 9.49M 8.63M 16.23M 1.12B 16.48M 111M 43.56M 560M 43.84M 42.89M 1.86B | P/E 2026 * |
20.5x | P/E 2027 * | 2.93x |
|---|---|---|---|---|---|
| Enterprise Value | 11.68M 10.09M 9.49M 8.63M 16.23M 1.12B 16.48M 111M 43.56M 560M 43.84M 42.89M 1.86B | EV / Sales 2026 * |
0.14x | EV / Sales 2027 * | 0.11x |
| Free-Float |
63.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.78% | ||
| 1 week | -7.56% | ||
| Current month | -4.17% | ||
| 1 month | -12.01% | ||
| 3 months | -31.50% | ||
| 6 months | -43.40% | ||
| Current year | -58.51% |
| 1 week | 0.2 |  | 0.22 |
| 1 month | 0.18 | | 0.25 |
| Current year | 0.16 | | 0.59 |
| 1 year | 0.16 | | 1.32 |
| 3 years | 0.16 | | 2.05 |
| 5 years | 0.16 | | 150 |
| 10 years | 0.16 | | 312.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Grigorios Siokas
CEO | Chief Executive Officer | 60 | 26/02/2016 |
Georgios Terzis
DFI | Director of Finance/CFO | 43 | 11/11/2020 |
| Chief Operating Officer | 56 | 01/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 13/01/2014 | |
Grigorios Siokas
CHM | Chairman | 60 | 26/02/2016 |
John Hoidas
BRD | Director/Board Member | 59 | 18/11/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/30/26 A | Buy | Chief Executive Officer | 349,825 | 0.5635% | ||
| 7/29/26 A | Free | Chief Financial Officer | 328,407 | 0.5290% | ||
| 7/29/26 A | Buy | Chief Executive Officer | 766,284 | 1.2344% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.78% | -7.56% | -76.92% | -86.04% | 11.68M | |
| +1.09% | -1.21% | +29.15% | +108.48% | 100B | |
| -0.29% | -0.93% | +57.06% | +172.00% | 54.81B | |
| -1.69% | -2.03% | +2.11% | +281.58% | 24.13B | |
| -0.24% | -1.73% | -12.65% | -16.13% | 8.19B | |
| -1.70% | -2.33% | -32.71% | -24.87% | 7.66B | |
| +0.65% | -0.88% | -13.59% | -20.61% | 6.68B | |
| +1.76% | +5.58% | +12.39% | +20.87% | 6.42B | |
| 0.00% | -1.52% | -3.17% | +15.56% | 4.98B | |
| -0.60% | -1.78% | -7.12% | -9.61% | 3.69B | |
| Average | -0.02% | -1.51% | -4.55% | +44.12% | 21.68B | |
| Weighted average by Cap. | +0.24% | -1.34% | +26.26% | +123.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 84.3M 72.83M 68.47M 62.3M 117M 8.06B 119M 803M 314M 4.04B 316M 310M 13.46B | 111M 95.72M 90M 81.88M 154M 10.6B 156M 1.06B 413M 5.31B 416M 407M 17.68B |
| Net income | - | - |
| Net Debt | - | - |
Employees
163
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | $0.2066 | +0.78% | 2,208,422 |
| 17/08/26 | $0.2050 | -5.92% | 1,640,747 |
| 14/08/26 | $0.2179 | +5.52% | 953,969 |
| 13/08/26 | $0.2065 | -0.29% | 1,406,018 |
| 12/08/26 | $0.2071 | -5.78% | 1,961,585 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COSM Stock
Select your edition
All financial news and data tailored to specific country editions
